Berubicin Hydrochloride

N/A

Report date: 2024/01/05 16:42:48
NME

Base Information

Drug NameBerubicin Hydrochloride
Drug Alias Name่ดๆŸ”ๆฏ”ๆ˜Ÿ็›้…ธ็›BerubicinumBerubicina่ด่Šฆๆฏ”ๆ˜Ÿ็›้…ธ็›Berubicin +[10]ย 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTopoisomerase II inhibitors
TargetsTopoisomerase II
Therapy Area/IndicationsBrain metastasesSolid tumoursMeningeal Carcinomatosis +[8]ย 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPolandItaly +[6]ย 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Texas MD Anderson Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesCns Pharmaceuticals Inc
Inactive CompaniesBiogen IncThe University Of Texas MD Anderson Cancer CenterWPD Pharmaceuticals Sp zoo +[4]ย 
Active IndicationsGlioblastoma
Inactive IndicationsBrain metastasesSolid tumoursMeningeal Carcinomatosis +[7]ย 

Other Information

ATC CodeN/A
Related LinksKEGG